Independent testing through DHS RIVR program exposes meaningful separation in real-world performance across the ...

Efgartigimod alfa–hyaluronidase significantly improves ocular symptoms in adults with ocular myasthenia gravis, according to phase 3 trial data.

CagriSema did not meet the noninferiority threshold for weight loss compared with tirzepatide in a phase 3 trial of patients with obesity.

On 20 February this year, your Board announced that the Company had, subject to shareholder approval, agreed a proposed combination of assets (the “Combination”) with BlackRock Smaller Companies Trust ...

Use our mortgage calculators to help you work out how repayments will affect your household finances, if you could save money ...